Gene · 54583
Papers3,727
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 3,727
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Markers of Restenosis after Percutaneous Transluminal Balloon Angioplasty in Patients with Critical Limb Ischemia. | Int J Mol Sci | 2023 | 37240440 | PubTator, text mining | PubMed |
| Dominant-negative heterozygous mutations in AIRE confer diverse autoimmune phenotypes. | iScience | 2023 | 37235056 | PubTator, text mining | PubMed |
| The Intriguing Role of Hypoxia-Inducible Factor in Myocardial Ischemia and Reperfusion: A Comprehensive Review. | J Cardiovasc Dev Dis | 2023 | 37233182 | PubTator, text mining | PubMed |
| BAF45D regulates spinal cord neural stem/progenitor cell fate through the SMAD-PAX6 axis. | Genes Dis | 2023 | 37223506 | PubTator, text mining | PubMed |
| Small extracellular vesicle-mediated metabolic reprogramming: from tumors to pre-metastatic niche formation. | Cell Commun Signal | 2023 | 37208722 | PubTator, text mining | PubMed |
| Expression of placental glycans and its role in regulating peripheral blood NK cells during preeclampsia: a perspective. | Front Endocrinol (Lausanne) | 2023 | 37206444 | PubTator, text mining | PubMed |
| Hypoxia inducible factor prolyl hydroxylases in inflammatory bowel disease. | Front Pharmacol | 2023 | 37201028 | PubTator, text mining | PubMed |
| The NF-κB Transcriptional Network Is a High-Dose Vitamin C-Targetable Vulnerability in Breast Cancer. | Biomedicines | 2023 | 37189677 | PubTator, text mining | PubMed |
| Antitumor effects and potential mechanisms of aconitine based on preclinical studies: an updated systematic review and meta-analysis. | Front Pharmacol | 2023 | 37180714 | PubTator, text mining | PubMed |
| Comprehensive Genetic Study of Malignant Cervical Paraganglioma. | Int J Mol Sci | 2023 | 37175927 | PubTator, text mining | PubMed |
Bacterial Lysate from the Multi-Strain Probiotic SLAB51 Triggers Adaptative Responses to Hypoxia in Human Caco-2 Intestinal Epithelial Cells under Normoxic Conditions and Attenuates LPS-Induced Inflammatory Response. | Int J Mol Sci | 2023 | 37175841 | PubTator, text mining | PubMed |
| The Role of HIF-1α in Bone Regeneration: A New Direction and Challenge in Bone Tissue Engineering. | Int J Mol Sci | 2023 | 37175732 | PubTator, text mining | PubMed |
| Hypoxic Stress-Dependent Regulation of Na,K-ATPase in Ischemic Heart Disease. | Int J Mol Sci | 2023 | 37175562 | PubTator, text mining | PubMed |
| Molecular Characterization and Functional Analysis of Hypoxia-Responsive Factor Prolyl Hydroxylase Domain 2 in Mandarin Fish (Siniperca chuatsi). | Animals (Basel) | 2023 | 37174593 | PubTator, text mining | PubMed |
| Angiogenic signaling pathways and anti-angiogenic therapy for cancer. | Signal Transduct Target Ther | 2023 | 37169756 | PubTator, text mining | PubMed |
| The landscape of exosomal non-coding RNAs in breast cancer drug resistance, focusing on underlying molecular mechanisms. | Front Pharmacol | 2023 | 37153758 | PubTator, text mining | PubMed |
| Predicting Environmental and Ecological Drivers of Human Population Structure. | Mol Biol Evol | 2023 | 37146165 | PubTator, text mining | PubMed |
| Editorial: Targeting tumor vasculature to enhance cancer immunotherapy. | Front Oncol | 2023 | 37143939 | PubTator, text mining | PubMed |
| Mechanism of assembly, activation and lysine selection by the SIN3B histone deacetylase complex. | Nat Commun | 2023 | 37137925 | PubTator, text mining | PubMed |
Effects of hypoxia-inducible factor prolyl hydroxylase inhibitors versus erythropoiesis-stimulating agents on iron metabolism and inflammation in patients undergoing dialysis: A systematic review and meta-analysis. | Heliyon | 2023 | 37123954 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54583/papers?page=22